State-level psychedelic policy is not moving in a single direction. Oregon now has a real operating psilocybin program, while Washington is still fighting over what kind of system it wants to build.
Oregon: A Real Program, Still a Narrow One
Oregon is no longer a hypothetical. The Oregon Health Authority says Oregon Psilocybin Services implements Ballot Measure 109, now codified at ORS 475A. The section began accepting license applications on January 2, 2023, and licensed psilocybin service centers began opening to clients in the summer of 2023.
That matters because Oregon has moved past the legalization-as-headline phase and into the harder work of operating a regulated system. In its 2024 Year in Review, Oregon Health Authority said that as of December 31, 2024 there were 345 licensed facilitators, 31 licensed service centers, 11 licensed manufacturers, 1 licensed laboratory, 724 worker permits, and 22 approved training programs. In the official 2025 Spring Newsletter, OHA said that as of March 31, 2025 the system had grown to 374 facilitators, with 29 service centers, 10 manufacturers, 1 laboratory, and 808 worker permits.
The 2024 OHA review also gives a more grounded sense of actual activity. It says 18,424 psilocybin products had been sold by licensed service centers to clients for administration sessions by the end of 2024, while cautioning that the figure may include secondary doses and only offers "a glimpse at how many clients may have accessed services."
So Oregon's situation is more complicated than either triumphalism or failure talk suggests. The program is clearly real, but it is also still highly managed, tightly licensed, and only beginning to generate fuller statewide reporting.
Washington: A Medical Model, Still Stuck in Committee
Washington, meanwhile, is not simply copying Oregon. The official state legislature summary identifies SB 5921 in the 2025-26 biennium as "Concerning psilocybin" and currently lists its status as "SWays & Means." The bill history shows it was first referred to Health & Long-Term Care, received an HLTC majority do pass recommendation, and was then referred onward to Ways & Means.
The bill text makes clear that Washington is debating a more clinical model than Oregon's service-center system. The proposal says it may be cited as the Washington medical psilocybin act and would create a medical use of psilocybin program under the supervision of the department of health. It defines clinicians approved by the department, qualified patients, inpatient medical services, outpatient microdose monitoring, and producers licensed by the department.
That is a very different policy posture from a broad access or decriminalization model. Washington is still in the stage of choosing what legal psilocybin should even be.
The Pattern
Oregon shows that a state can move from ballot language to a functioning regulated psilocybin system, but only through a dense administrative structure and slow, official data collection. Washington shows that other states may prefer a more medicalized, health-department-led path, and may still stall even when a formal bill exists.
That is why state-level psychedelic policy is getting more complicated. The question is no longer just whether states will move. It is what kind of access they are willing to build, and under whose supervision.